Chemicals Financing Activity Declines (Y&P article in ICIS Chemical Business Nov 29 – Dec 5, 2019)
Young & Partners documents the decline in debt and equity financing and the underlying trends
Megadeals done, M&A volumes remain flat (Chemical Week July 22, 2019 issue)
Editor-in-Chief interviews Peter Young about the Chemical M&A market developments
Pharma and Biotech – Financial Check and Outlook (Y&P article in Pharma Exec, July 2019 issue)
Young & Partners examples the strategic, M&A, and financial health of Biopharma
Chemicals M&A in Transition (Y&P article in ICIS Chemical Business, June 14-20, 2019)
Analysis of the M&A market: Shifting Valuations, Healthy Volumes, Death of Mega Deals
M&A Values Hold Strong But Volume Dips (Chemweek March 11-18, 2019)
Young & Partners data shows high total dollars in 2018, but underlying volumes slid
Chemicals M&A at Inflection Point (Y&P article in ICIS March 1-7, 2019 issue)
Transaction trends differ greatly, depending on sector and geography.
CFIUS Reform’s Impact on Biopharma (Phama Exec February 2019 issue)
What the new rules mean for Chinese-related investments and acquisitions in the US
Chemical Week – Young & Partners M&A Interview (Nov 5, 2018 issue)
Young & Partners looks at the chemical M&A market and the role of the mega deals
Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issue
Young & Partners’ provides its analysis of what is happening in the stock market and financing worlds.
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)
An in depth look at strategic, M&A and financial trends for Pharma and Biotech